AQUESTIVE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.09 USD | -6.08% |
|
-12.22% | +52.97% |
| 10/05 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
| 08/05 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 3.850 | 6.090 | 6.090 |
| Spread/Res. | -19.74% | -49.26% | -49.26% |
| Spread/Supp. | +0.16% | +10.75% | +12.36% |
| Support | 3.085 | 2.790 | 2.750 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AQST Stock
- Charts Aquestive Therapeutics, Inc.